Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Apr;36(2):128-133.
doi: 10.1016/j.jpag.2022.12.001. Epub 2022 Dec 5.

Effects of Ovarian Tissue Cryopreservation on Primary Ovarian Insufficiency in Girls Undergoing Bone Marrow Transplantation

Maggie Dwiggins  1 , Jessica Shim  2 , Lan Anh Galloway  3 , Holly Hoefgen  4 , Vrunda Patel  5 , Lesley Breech  6 , Veronica Gomez-Lobo  7
Affiliations
Multicenter Study

Effects of Ovarian Tissue Cryopreservation on Primary Ovarian Insufficiency in Girls Undergoing Bone Marrow Transplantation

Maggie Dwiggins et al. J Pediatr Adolesc Gynecol. 2023 Apr.

Abstract

Objective: To determine if removing an ovary for ovarian tissue cryopreservation (OTC) increased rates of primary ovarian insufficiency (POI) in girls undergoing bone marrow transplantation (BMT). Institutional review board approval was obtained from all 3 clinical sites.

Design: Multicenter retrospective cohort study SETTING: Academic children's hospitals PATIENTS: Females aged 2-21 who underwent BMT with or without OTC from 2010 to 2017.

Interventions: None MAIN OUTCOME MEASURES: Rates of POI in girls who underwent OTC vs those who underwent BMT alone as determined by serum markers, presence of menses, or clinical diagnosis.

Results: A total of 142 patients were identified, 43 who had OTC and 99 with BMT alone. The rate of POI in girls undergoing OTC was 65% vs 41.8% in those who underwent BMT alone (P = .26).

Conclusions: Although this study was not powered to detect a lack of difference, it is reassuring that there does not seem to be a clinically significant increase in POI in patients undergoing OTC.

Keywords: Bone marrow transplant; Fertility preservation; Ovarian tissue cryopreservation; Premature ovarian insufficiency.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Inclusion/exclusion of patients due to pubertal status for determining primary ovarian insufficiency (POI).
Fig. 2.
Fig. 2.
Primary ovarian insufficiency (POI) diagnosis based on lab values vs other factors.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Hamish W, Wallace B, Anderson RA, Irvine DS: Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005; 6:209–18. - PubMed
    1. Pascale J, Donnez J: How does bone marrow transplantation affect ovarian function and fertility? Curr Opin Obstet Gynecol 2012; 24:164–71. - PubMed
    1. Meacham LR, Burns K, Orwig KE, Levine J: Standardizing risk assessment for treatment-related gonadal insufficiency and infertility in childhood adolescent and young adult cancer: the Pediatric initiative Network risk stratification system. J Adolesc Young Adult Oncol 2020; 9:662–6. - PubMed
    1. Shapira M, Raanani H, Cohen Y, Meirow D: Fertility preservation in young females with hematological malignancies. Acta Haematol 2014; 132:400–13. - PubMed
    1. Logan S, Perz J, Ussher J, et al.: Clinician provision of oncofertility support in cancer patients of a reproductive age: a systematic review. Psychooncology 2018; 27:748. - PubMed

Publication types